Atlas Trials

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease

Clinical trial NCT01461837 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01461837
Sponsor
New York Medical College
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2012-01-01
Primary completion
2025-12-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.